Bedal International, a pioneering medical device company specializing in advanced catheter securement solutions, has successfully concluded an $11 million funding round aimed at accelerating its global expansion efforts. The funding will bolster Bedal’s capacity to further innovate and meet the growing demand for its flagship product, the FlexGRIP® catheter securement devices.
Led by Belgian MedTech venture capital fund White Fund and SFPIM, Belgium’s sovereign wealth fund, the investment round also saw participation from prominent U.S.-based MedTech investors, alongside existing backers F3Finance and LRM. This funding milestone underscores Bedal’s commitment to enhancing patient care through innovative medical technologies.
Alexander Van Damme, CEO of Bedal International, expressed optimism about the company’s future trajectory: “This funding marks a pivotal moment for Bedal as we continue to set new standards in catheter care. Our goal is to ensure safer and more effective healthcare solutions globally.”
Bedal’s FlexGRIP devices are currently deployed in over 34 countries, playing a crucial role in minimizing complications associated with catheter usage across various medical applications, including oncology, post-operative care, and intensive care units. The recent influx of capital will enable Bedal to strengthen its presence in key markets, particularly in the United States, where demand for advanced medical technologies remains robust.
“White Fund and SFPIM are proud to support Bedal in its mission to revolutionize patient care through innovative medical devices,” remarked Eric Brandt of White Fund. Céline Vaessen, CIO at SFPIM, added, “We believe in Bedal’s potential to lead the industry with its pioneering approach to catheter securement solutions.”
Dr. Steve Bierman, a luminary in the medical device industry and co-CEO at Bedal, highlighted the company’s commitment to improving healthcare outcomes: “Our focus on patient-centric innovations continues to drive Bedal forward. We are dedicated to leveraging our expertise to address critical healthcare challenges globally.”
Founded with a vision to address the complexities of catheter care, Bedal International remains steadfast in its pursuit of excellence in medical device innovation. The company’s expansion efforts and technological advancements underscore its pivotal role in shaping the future of healthcare.
Editorial Opinion:
Bedal International’s recent funding achievement not only highlights its robust growth trajectory but also underscores its pivotal role in advancing medical device innovations. With a strong focus on patient safety and healthcare efficiency, Bedal’s FlexGRIP® catheter securement devices exemplify the company’s commitment to setting new standards in medical care. As the global demand for innovative healthcare solutions continues to rise, Bedal is well-positioned to capitalize on emerging opportunities and expand its influence in the medical technology sector. By prioritizing product innovation and strategic market expansion, Bedal International is poised to make a lasting impact on healthcare delivery worldwide.
If you need further assistance or have any corrections, please reach out to editor@thetimesmag.com.
